UFIS-SWE-IG
0.1.0 - ci-build
UFIS-SWE-IG
0.1.0 - ci-build
UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions
<Bundle xmlns="http://hl7.org/fhir">
<id value="Levaxin-200mg-Tablet-SE-BS-MPD-BBDL"/>
<type value="collection"/>
<entry>
<fullUrl
value="https://hl7-eu.github.io/unicom-ig/branches/mpd-r4b/MedicinalProductDefinition/Levaxin-200mg-Tablet-SE-BS-MPD"/>
<resource>
<MedicinalProductDefinition>
<id value="Levaxin-200mg-Tablet-SE-BS-MPD"/>
<meta>
<profile
value="http://unicom-project.eu/fhir/StructureDefinition/PPLMedicinalProductDefinition"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="MedicinalProductDefinition_Levaxin-200mg-Tablet-SE-BS-MPD"> </a><p class="res-header-id"><b>Generated Narrative: MedicinalProductDefinition Levaxin-200mg-Tablet-SE-BS-MPD</b></p><a name="Levaxin-200mg-Tablet-SE-BS-MPD"> </a><a name="hcLevaxin-200mg-Tablet-SE-BS-MPD"> </a><a name="hcLevaxin-200mg-Tablet-SE-BS-MPD-en-US"> </a><p><b>identifier</b>: <code>http://ema.europa.eu/fhir/mpId</code>/SE-XXXXXXXXX-00021055, <code>http://ema.europa.eu/fhir/eurdId</code>/1860</p><p><b>domain</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000000004 100000000012}">Human use</span></p><p><b>status</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/200000005003 200000005004}">Current</span></p><p><b>combinedPharmaceuticalDoseForm</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/200000000004~200000000006~200000000007~200000000008 100000073664}">Tablet</span></p><p><b>indication</b>: </p><div><p>Hypotyreos av alla former t ex vid autoimmun tyreoidit, efter radiojod- och kirurgisk terapi av hypertyreos och vid progressiv oftalmopati när den är förenad med hypotyreos. Som tillägg till tyreostatika vid långtidsbehandling av hypertyreos och vid preoperativ kombinationsbehandling av hypertyreos. Tyreoideacancer. Myxödemkoma.</p>
</div><p><b>legalStatusOfSupply</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000072051 100000072084}">Medicinal product subject to medical prescription</span></p><p><b>classification</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000093533 100000096060}">levothyroxine sodium</span></p><blockquote><p><b>name</b></p><p><b>productName</b>: Levaxin 200 mikrogram tablett</p><blockquote><p><b>part</b></p><p><b>part</b>: Levaxin</p><p><b>type</b>: <span title="Codes:{http://spor.ema.europa.eu/v1/lists/220000000000 220000000003}">Scientific name part</span></p></blockquote><blockquote><p><b>part</b></p><p><b>part</b>: 200 mikrogram</p><p><b>type</b>: <span title="Codes:{http://spor.ema.europa.eu/v1/lists/220000000000 220000000004}">Strength part</span></p></blockquote><blockquote><p><b>part</b></p><p><b>part</b>: Tablett</p><p><b>type</b>: <span title="Codes:{http://spor.ema.europa.eu/v1/lists/220000000000 220000000005}">Pharmaceutical dose form part</span></p></blockquote><h3>Usages</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Country</b></td><td><b>Language</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000000002 100000000535}">Kingdom of Sweden</span></td><td><span title="Codes:{urn:ietf:bcp:47 sv}">Swedish</span></td></tr></table></blockquote></div>
</text>
<identifier>
<system value="http://ema.europa.eu/fhir/mpId"/>
<value value="SE-XXXXXXXXX-00021055"/>
</identifier>
<identifier>
<system value="http://ema.europa.eu/fhir/eurdId"/>
<value value="1860"/>
</identifier>
<domain>
<coding>
<system value="https://spor.ema.europa.eu/v1/lists/100000000004"/>
<code value="100000000012"/>
<display value="Human use"/>
</coding>
</domain>
<status>
<coding>
<system value="https://spor.ema.europa.eu/v1/lists/200000005003"/>
<code value="200000005004"/>
<display value="Current"/>
</coding>
</status>
<combinedPharmaceuticalDoseForm>
<coding>
<system
value="https://spor.ema.europa.eu/v1/lists/200000000004~200000000006~200000000007~200000000008"/>
<code value="100000073664"/>
<display value="Tablet"/>
</coding>
</combinedPharmaceuticalDoseForm>
<indication
value="Hypotyreos av alla former t ex vid autoimmun tyreoidit, efter radiojod- och kirurgisk terapi av hypertyreos och vid progressiv oftalmopati när den är förenad med hypotyreos. Som tillägg till tyreostatika vid långtidsbehandling av hypertyreos och vid preoperativ kombinationsbehandling av hypertyreos. Tyreoideacancer. Myxödemkoma."/>
<legalStatusOfSupply>
<coding>
<system value="https://spor.ema.europa.eu/v1/lists/100000072051"/>
<code value="100000072084"/>
<display
value="Medicinal product subject to medical prescription"/>
</coding>
</legalStatusOfSupply>
<classification>
<coding>
<system value="https://spor.ema.europa.eu/v1/lists/100000093533"/>
<code value="100000096060"/>
<display value="levothyroxine sodium"/>
</coding>
</classification>
<name>
<productName value="Levaxin 200 mikrogram tablett"/>
<part>
<part value="Levaxin"/>
<type>
<coding>
<system
value="http://spor.ema.europa.eu/v1/lists/220000000000"/>
<code value="220000000003"/>
<display value="Scientific name part"/>
</coding>
</type>
</part>
<part>
<part value="200 mikrogram"/>
<type>
<coding>
<system
value="http://spor.ema.europa.eu/v1/lists/220000000000"/>
<code value="220000000004"/>
<display value="Strength part"/>
</coding>
</type>
</part>
<part>
<part value="Tablett"/>
<type>
<coding>
<system
value="http://spor.ema.europa.eu/v1/lists/220000000000"/>
<code value="220000000005"/>
<display value="Pharmaceutical dose form part"/>
</coding>
</type>
</part>
<usage>
<country>
<coding>
<system
value="https://spor.ema.europa.eu/v1/lists/100000000002"/>
<code value="100000000535"/>
<display value="Kingdom of Sweden"/>
</coding>
</country>
<language>
<coding>
<system value="urn:ietf:bcp:47"/>
<code value="sv"/>
<display value="Swedish"/>
</coding>
</language>
</usage>
</name>
</MedicinalProductDefinition>
</resource>
</entry>
<entry>
<fullUrl
value="https://hl7-eu.github.io/unicom-ig/branches/mpd-r4b/RegulatedAuthorization/Levaxin-200mg-Tablet-SE-BS-RA"/>
<resource>
<RegulatedAuthorization>
<id value="Levaxin-200mg-Tablet-SE-BS-RA"/>
<meta>
<profile
value="http://unicom-project.eu/fhir/StructureDefinition/PPLRegulatedAuthorization"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="RegulatedAuthorization_Levaxin-200mg-Tablet-SE-BS-RA"> </a><p class="res-header-id"><b>Generated Narrative: RegulatedAuthorization Levaxin-200mg-Tablet-SE-BS-RA</b></p><a name="Levaxin-200mg-Tablet-SE-BS-RA"> </a><a name="hcLevaxin-200mg-Tablet-SE-BS-RA"> </a><a name="hcLevaxin-200mg-Tablet-SE-BS-RA-en-US"> </a><p><b>identifier</b>: <code>http://ema.europa.eu/fhir/marketingAuthorizationNumber</code>/21055</p><p><b>subject</b>: <a href="MedicinalProductDefinition-Levaxin-200mg-Tablet-SE-BS-MPD.html">MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-XXXXXXXXX-00021055,http://ema.europa.eu/fhir/eurdId#1860; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Tablet; indication = Hypotyreos av alla former t ex vid autoimmun tyreoidit, efter radiojod- och kirurgisk terapi av hypertyreos och vid progressiv oftalmopati när den är förenad med hypotyreos. Som tillägg till tyreostatika vid långtidsbehandling av hypertyreos och vid preoperativ kombinationsbehandling av hypertyreos. Tyreoideacancer. Myxödemkoma.; legalStatusOfSupply = Medicinal product subject to medical prescription; classification = levothyroxine sodium</a></p><p><b>type</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/220000000060 220000000061}">Marketing Authorisation</span></p><p><b>region</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000000002 100000000535}">Kingdom of Sweden</span></p><p><b>status</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000072049 100000072099}">Valid</span></p><p><b>statusDate</b>: 2005-09-16</p><p><b>holder</b>: <a href="Organization-LOC-XXXXXXXXX.html">Organization Orifarm Healthcare A/S</a></p><h3>Cases</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Type</b></td><td><b>Date[x]</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{https://ema.europa.eu/fhir/authorisationDateType dateOfFirstAuthorisation}">First Authorisation</span></td><td>2005-09-16</td></tr></table></div>
</text>
<identifier>
<system
value="http://ema.europa.eu/fhir/marketingAuthorizationNumber"/>
<value value="21055"/>
</identifier>
<subject>🔗
<reference
value="MedicinalProductDefinition/Levaxin-200mg-Tablet-SE-BS-MPD"/>
</subject>
<type>
<coding>
<system value="https://spor.ema.europa.eu/v1/lists/220000000060"/>
<code value="220000000061"/>
<display value="Marketing Authorisation"/>
</coding>
</type>
<region>
<coding>
<system value="https://spor.ema.europa.eu/v1/lists/100000000002"/>
<code value="100000000535"/>
<display value="Kingdom of Sweden"/>
</coding>
</region>
<status>
<coding>
<system value="https://spor.ema.europa.eu/v1/lists/100000072049"/>
<code value="100000072099"/>
<display value="Valid"/>
</coding>
</status>
<statusDate value="2005-09-16"/>
<holder>🔗
<reference value="Organization/LOC-XXXXXXXXX"/>
</holder>
<case>
<type>
<coding>
<system
value="https://ema.europa.eu/fhir/authorisationDateType"/>
<code value="dateOfFirstAuthorisation"/>
<display value="First Authorisation"/>
</coding>
</type>
<dateDateTime value="2005-09-16"/>
</case>
</RegulatedAuthorization>
</resource>
</entry>
<entry>
<fullUrl
value="https://hl7-eu.github.io/unicom-ig/branches/mpd-r4b/PackagedProductDefinition/Levaxin-200mg-Tablet-SE-BS-PPD"/>
<resource>
<PackagedProductDefinition>
<id value="Levaxin-200mg-Tablet-SE-BS-PPD"/>
<meta>
<profile
value="http://unicom-project.eu/fhir/StructureDefinition/PPLPackagedProductDefinition"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="PackagedProductDefinition_Levaxin-200mg-Tablet-SE-BS-PPD"> </a><p class="res-header-id"><b>Generated Narrative: PackagedProductDefinition Levaxin-200mg-Tablet-SE-BS-PPD</b></p><a name="Levaxin-200mg-Tablet-SE-BS-PPD"> </a><a name="hcLevaxin-200mg-Tablet-SE-BS-PPD"> </a><a name="hcLevaxin-200mg-Tablet-SE-BS-PPD-en-US"> </a><p><b>identifier</b>: <code>http://ema.europa.eu/example/pcid</code>/?ngen-9?</p><p><b>packageFor</b>: <a href="MedicinalProductDefinition-Levaxin-200mg-Tablet-SE-BS-MPD.html">MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-XXXXXXXXX-00021055,http://ema.europa.eu/fhir/eurdId#1860; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Tablet; indication = Hypotyreos av alla former t ex vid autoimmun tyreoidit, efter radiojod- och kirurgisk terapi av hypertyreos och vid progressiv oftalmopati när den är förenad med hypotyreos. Som tillägg till tyreostatika vid långtidsbehandling av hypertyreos och vid preoperativ kombinationsbehandling av hypertyreos. Tyreoideacancer. Myxödemkoma.; legalStatusOfSupply = Medicinal product subject to medical prescription; classification = levothyroxine sodium</a></p><p><b>containedItemQuantity</b>: 100 Tablet<span style="background: LightGoldenRodYellow"> (Details: 200000000014 code200000002152 = '200000002152')</span></p><p><b>description</b>: </p><div><p>Burk, 100 tabletter</p>
</div><h3>MarketingStatuses</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Country</b></td><td><b>Status</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000000002 100000000535}">Kingdom of Sweden</span></td><td><span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000072052 100000072083}">Marketed</span></td></tr></table><blockquote><p><b>packaging</b></p><p><b>type</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000073346 100000073498}">Box</span></p><p><b>quantity</b>: 1</p><p><b>material</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/200000003199 200000003529}">Cardboard</span></p><blockquote><p><b>packaging</b></p></blockquote></blockquote></div>
</text>
<identifier>
<system value="http://ema.europa.eu/example/pcid"/>
</identifier>
<packageFor>🔗
<reference
value="MedicinalProductDefinition/Levaxin-200mg-Tablet-SE-BS-MPD"/>
</packageFor>
<containedItemQuantity>
<value value="100"/>
<unit value="Tablet"/>
<system value="http://spor.ema.europa.eu/v1/lists/200000000014"/>
<code value="200000002152"/>
</containedItemQuantity>
<description value="Burk, 100 tabletter"/>
<marketingStatus>
<country>
<coding>
<system
value="https://spor.ema.europa.eu/v1/lists/100000000002"/>
<code value="100000000535"/>
<display value="Kingdom of Sweden"/>
</coding>
</country>
<status>
<coding>
<system
value="https://spor.ema.europa.eu/v1/lists/100000072052"/>
<code value="100000072083"/>
<display value="Marketed"/>
</coding>
</status>
</marketingStatus>
<packaging>
<type>
<coding>
<system
value="https://spor.ema.europa.eu/v1/lists/100000073346"/>
<code value="100000073498"/>
<display value="Box"/>
</coding>
</type>
<quantity value="1"/>
<material>
<coding>
<system
value="https://spor.ema.europa.eu/v1/lists/200000003199"/>
<code value="200000003529"/>
<display value="Cardboard"/>
</coding>
</material>
<packaging>
<type>
<coding>
<system
value="https://spor.ema.europa.eu/v1/lists/100000073346"/>
<code value="100000073497"/>
<display value="Bottle"/>
</coding>
</type>
<quantity value="1"/>
<material>
<coding>
<system
value="https://spor.ema.europa.eu/v1/lists/200000003199"/>
<code value="200000003215"/>
<display value="High Density PolyEthylene"/>
</coding>
<coding>
<system
value="https://spor.ema.europa.eu/v1/lists/200000003199"/>
<code value="200000003216"/>
<display value="Low Density PolyEthylene"/>
</coding>
</material>
<containedItem>
<item>
<reference>🔗
<reference
value="ManufacturedItemDefinition/Levaxin-200mg-Tablet-SE-BS-MID"/>
</reference>
</item>
<amount>
<value value="100"/>
<unit value="Tablet"/>
<system
value="http://spor.ema.europa.eu/v1/lists/100000110633~200000000014"/>
<code value="200000002152"/>
</amount>
</containedItem>
</packaging>
</packaging>
</PackagedProductDefinition>
</resource>
</entry>
<entry>
<fullUrl
value="https://hl7-eu.github.io/unicom-ig/branches/mpd-r4b/ManufacturedItemDefinition/Levaxin-200mg-Tablet-SE-BS-MID"/>
<resource>
<ManufacturedItemDefinition>
<id value="Levaxin-200mg-Tablet-SE-BS-MID"/>
<meta>
<profile
value="http://unicom-project.eu/fhir/StructureDefinition/PPLManufacturedItemDefinition"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="ManufacturedItemDefinition_Levaxin-200mg-Tablet-SE-BS-MID"> </a><p class="res-header-id"><b>Generated Narrative: ManufacturedItemDefinition Levaxin-200mg-Tablet-SE-BS-MID</b></p><a name="Levaxin-200mg-Tablet-SE-BS-MID"> </a><a name="hcLevaxin-200mg-Tablet-SE-BS-MID"> </a><a name="hcLevaxin-200mg-Tablet-SE-BS-MID-en-US"> </a><p><b>status</b>: Active</p><p><b>manufacturedDoseForm</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/200000000004 100000073664}">Tablet</span></p><p><b>unitOfPresentation</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/200000000014 200000002152}">Tablet</span></p></div>
</text>
<status value="active"/>
<manufacturedDoseForm>
<coding>
<system value="https://spor.ema.europa.eu/v1/lists/200000000004"/>
<code value="100000073664"/>
<display value="Tablet"/>
</coding>
</manufacturedDoseForm>
<unitOfPresentation>
<coding>
<system value="https://spor.ema.europa.eu/v1/lists/200000000014"/>
<code value="200000002152"/>
<display value="Tablet"/>
</coding>
</unitOfPresentation>
</ManufacturedItemDefinition>
</resource>
</entry>
<entry>
<fullUrl
value="https://hl7-eu.github.io/unicom-ig/branches/mpd-r4b/Ingredient/Levaxin-200mg-Tablet-SE-BS-ING"/>
<resource>
<Ingredient>
<id value="Levaxin-200mg-Tablet-SE-BS-ING"/>
<meta>
<profile
value="http://unicom-project.eu/fhir/StructureDefinition/PPLIngredient"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="Ingredient_Levaxin-200mg-Tablet-SE-BS-ING"> </a><p class="res-header-id"><b>Generated Narrative: Ingredient Levaxin-200mg-Tablet-SE-BS-ING</b></p><a name="Levaxin-200mg-Tablet-SE-BS-ING"> </a><a name="hcLevaxin-200mg-Tablet-SE-BS-ING"> </a><a name="hcLevaxin-200mg-Tablet-SE-BS-ING-en-US"> </a><p><b>status</b>: Active</p><p><b>for</b>: </p><ul><li><a href="MedicinalProductDefinition-Levaxin-200mg-Tablet-SE-BS-MPD.html">MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-XXXXXXXXX-00021055,http://ema.europa.eu/fhir/eurdId#1860; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Tablet; indication = Hypotyreos av alla former t ex vid autoimmun tyreoidit, efter radiojod- och kirurgisk terapi av hypertyreos och vid progressiv oftalmopati när den är förenad med hypotyreos. Som tillägg till tyreostatika vid långtidsbehandling av hypertyreos och vid preoperativ kombinationsbehandling av hypertyreos. Tyreoideacancer. Myxödemkoma.; legalStatusOfSupply = Medicinal product subject to medical prescription; classification = levothyroxine sodium</a></li><li><a href="ManufacturedItemDefinition-Levaxin-200mg-Tablet-SE-BS-MID.html">ManufacturedItemDefinition: status = active; manufacturedDoseForm = Tablet; unitOfPresentation = Tablet</a></li><li><a href="AdministrableProductDefinition-Levaxin-200mg-Tablet-SE-BS-APD.html">AdministrableProductDefinition: status = active; administrableDoseForm = Tablet</a></li></ul><p><b>role</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000072050 100000072072}">Active</span></p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{https://spor.azure-api.net/sms/api/v2/SubstanceDefinition 100000145050}">Anhydrous levothyroxine sodium</span></td></tr></table><blockquote><p><b>strength</b></p><p><b>presentation</b>: 205.7 microgram(s)<span style="background: LightGoldenRodYellow"> (Details: 100000110633 code100000110656 = '100000110656')</span>/1 tablet<span style="background: LightGoldenRodYellow"> (Details: 200000000014 code200000002152 = '200000002152')</span></p><blockquote><p><b>referenceStrength</b></p><h3>Substances</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{https://spor.azure-api.net/sms/api/v2/SubstanceDefinition 100000086128}">Levothyroxine</span></td></tr></table><p><b>strength</b>: 200 microgram(s)<span style="background: LightGoldenRodYellow"> (Details: Unit of Measurement EMA code100000110656 = 'microgram(s)')</span>/1 tablet<span style="background: LightGoldenRodYellow"> (Details: 200000000014 code200000002152 = '200000002152')</span></p></blockquote></blockquote></blockquote></div>
</text>
<status value="active"/>
<for>🔗
<reference
value="MedicinalProductDefinition/Levaxin-200mg-Tablet-SE-BS-MPD"/>
</for>
<for>🔗
<reference
value="ManufacturedItemDefinition/Levaxin-200mg-Tablet-SE-BS-MID"/>
</for>
<for>🔗
<reference
value="AdministrableProductDefinition/Levaxin-200mg-Tablet-SE-BS-APD"/>
</for>
<role>
<coding>
<system value="https://spor.ema.europa.eu/v1/lists/100000072050"/>
<code value="100000072072"/>
<display value="Active"/>
</coding>
</role>
<substance>
<code>
<concept>
<coding>
<system
value="https://spor.azure-api.net/sms/api/v2/SubstanceDefinition"/>
<code value="100000145050"/>
<display value="Anhydrous levothyroxine sodium"/>
</coding>
</concept>
</code>
<strength>
<presentationRatio>
<numerator>
<value value="205.7"/>
<unit value="microgram(s)"/>
<system
value="http://spor.ema.europa.eu/v1/lists/100000110633"/>
<code value="100000110656"/>
</numerator>
<denominator>
<value value="1"/>
<unit value="tablet"/>
<system
value="http://spor.ema.europa.eu/v1/lists/200000000014"/>
<code value="200000002152"/>
</denominator>
</presentationRatio>
<referenceStrength>
<substance>
<concept>
<coding>
<system
value="https://spor.azure-api.net/sms/api/v2/SubstanceDefinition"/>
<code value="100000086128"/>
<display value="Levothyroxine"/>
</coding>
</concept>
</substance>
<strengthRatio>
<numerator>
<value value="200"/>
<unit value="microgram(s)"/>
<system
value="https://spor.ema.europa.eu/v1/lists/100000110633"/>
<code value="100000110656"/>
</numerator>
<denominator>
<value value="1"/>
<unit value="tablet"/>
<system
value="http://spor.ema.europa.eu/v1/lists/200000000014"/>
<code value="200000002152"/>
</denominator>
</strengthRatio>
</referenceStrength>
</strength>
</substance>
</Ingredient>
</resource>
</entry>
<entry>
<fullUrl
value="https://hl7-eu.github.io/unicom-ig/branches/mpd-r4b/AdministrableProductDefinition/Levaxin-200mg-Tablet-SE-BS-APD"/>
<resource>
<AdministrableProductDefinition>
<id value="Levaxin-200mg-Tablet-SE-BS-APD"/>
<meta>
<profile
value="http://unicom-project.eu/fhir/StructureDefinition/PPLAdministrableProductDefinition"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="AdministrableProductDefinition_Levaxin-200mg-Tablet-SE-BS-APD"> </a><p class="res-header-id"><b>Generated Narrative: AdministrableProductDefinition Levaxin-200mg-Tablet-SE-BS-APD</b></p><a name="Levaxin-200mg-Tablet-SE-BS-APD"> </a><a name="hcLevaxin-200mg-Tablet-SE-BS-APD"> </a><a name="hcLevaxin-200mg-Tablet-SE-BS-APD-en-US"> </a><p><b>status</b>: Active</p><p><b>formOf</b>: <a href="MedicinalProductDefinition-Levaxin-200mg-Tablet-SE-BS-MPD.html">MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-XXXXXXXXX-00021055,http://ema.europa.eu/fhir/eurdId#1860; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Tablet; indication = Hypotyreos av alla former t ex vid autoimmun tyreoidit, efter radiojod- och kirurgisk terapi av hypertyreos och vid progressiv oftalmopati när den är förenad med hypotyreos. Som tillägg till tyreostatika vid långtidsbehandling av hypertyreos och vid preoperativ kombinationsbehandling av hypertyreos. Tyreoideacancer. Myxödemkoma.; legalStatusOfSupply = Medicinal product subject to medical prescription; classification = levothyroxine sodium</a></p><p><b>administrableDoseForm</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/200000000004 100000073664}">Tablet</span></p><p><b>producedFrom</b>: <a href="ManufacturedItemDefinition-Levaxin-200mg-Tablet-SE-BS-MID.html">ManufacturedItemDefinition: status = active; manufacturedDoseForm = Tablet; unitOfPresentation = Tablet</a></p><h3>RouteOfAdministrations</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Code</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000073345 100000073619}">Oral use</span></td></tr></table></div>
</text>
<status value="active"/>
<formOf>🔗
<reference
value="MedicinalProductDefinition/Levaxin-200mg-Tablet-SE-BS-MPD"/>
</formOf>
<administrableDoseForm>
<coding>
<system value="https://spor.ema.europa.eu/v1/lists/200000000004"/>
<code value="100000073664"/>
<display value="Tablet"/>
</coding>
</administrableDoseForm>
<producedFrom>🔗
<reference
value="ManufacturedItemDefinition/Levaxin-200mg-Tablet-SE-BS-MID"/>
</producedFrom>
<routeOfAdministration>
<code>
<coding>
<system
value="https://spor.ema.europa.eu/v1/lists/100000073345"/>
<code value="100000073619"/>
<display value="Oral use"/>
</coding>
</code>
</routeOfAdministration>
</AdministrableProductDefinition>
</resource>
</entry>
<entry>
<fullUrl
value="https://hl7-eu.github.io/unicom-ig/branches/mpd-r4b/Organization/LOC-XXXXXXXXX"/>
<resource>
<Organization>
<id value="LOC-XXXXXXXXX"/>
<meta>
<profile
value="http://unicom-project.eu/fhir/StructureDefinition/PPLOrganization"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="Organization_LOC-XXXXXXXXX"> </a><p class="res-header-id"><b>Generated Narrative: Organization LOC-XXXXXXXXX</b></p><a name="LOC-XXXXXXXXX"> </a><a name="hcLOC-XXXXXXXXX"> </a><a name="hcLOC-XXXXXXXXX-en-US"> </a><p><b>identifier</b>: <code>https://spor.ema.europa.eu/v1/locations</code>/LOC-XXXXXXXXX</p><p><b>name</b>: Orifarm Healthcare A/S</p></div>
</text>
<identifier>
<system value="https://spor.ema.europa.eu/v1/locations"/>
<value value="LOC-XXXXXXXXX"/>
</identifier>
<name value="Orifarm Healthcare A/S"/>
</Organization>
</resource>
</entry>
</Bundle>
IG © 2022+ UNICOM. Package hl7.eu.fhir.ufis-swe-unicom#0.1.0 based on FHIR 5.0.0. Generated 2024-06-28
Links: Table of Contents |
QA Report
The UNICOM Innovation Action has received funding from the European Union's Horizon 2020
research and innovation programme under grant agreement No. 875299.
